Dallas, TX -- (SBWIRE) -- 07/24/2015 -- RnRMarketResearch.com adds "Anticoagulants-Competitive Landscape, Market & Pipeline Analysis, Forecasted Market Size 2015-2018"to its store.
"Anticoagulants-Competitive Landscape, Market & Pipeline Analysis, Forecasted Market Size 2015-2018" analyzes that Anticoagulants has lot of future scope and potential in the market. Mostly anticoagulants are being used in Venous Thromboembolism and Atrial Fibrillation. There are 16 anticoagulants in pipeline for venous thromboembolism, Atrial Fibrillation, Acute Coronary Syndrome, Stroke and Myocardial Infarction.
DelveInsight analysis predicts that global VTE therapeutics market was worth USD 4 billion in 2014 and expected to reach USD 5.5 billion by 2018 with a Compound Annual Growth Rate (CAGR) of 8.29%.
DelveInsight analysis forecasts that global Atrial Fibrillation market will reach on its peak value USD 13.28 billion in 2018 from USD 7.86 billion in 2014 with compound annual growth rate (CAGR) of 14%.
The Anticoagulants' market is expected to decline after 2018 as many anticoagulants are going to be generic.
Inquire for discount on this report at http://www.rnrmarketresearch.com/contacts/discount?rname=366400
Overview of Anticoagulants, which includes its physiology, pathophysiology, diagnosis and treatment.
Report has covered the worldwide market of Anticoagulants, information of marketed molecules including patent expiry and detail profiling of Pipeline assets
Anticoagulants annual sales and forecasted sales of major player still 2018
Venous Thromboembolism and Atrial Fibrillation annual estimates and forecasts are provided along with historical analysis
Detailed epidemiology for every region as well as trends in epidemiology and Information of Antidotes for Anticoagulants which are in pipeline
Pipeline analysis: Comprehensive data split across different phases and emerging trends and therapeutic assessments by molecule type, route and mechanism of action
DelveInsight Anticoagulant report includes strategic competitor assessment, market characterization, opportunities, barriers, challenges and regulatory hurdles for the Anticoagulants market.
Analysis of the current and future market competition in the global Anticoagulants drug market. Insightful review of the key industry drivers, restraints and challenges.
Reasons to Buy
The Anticoagulant report covers complete Market and Pipeline intelligence and understanding over therapeutics development for Anticoagulants
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of therapeutics under development for Anticoagulants
DelveInsight Anti-coagulants report helps to develop business strategies by understanding the trends shaping and driving for Anticoagulants market
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Devise corrective measures for pipeline projects by understanding Anticoagulants pipeline in-depth
Develop and design in-licensing and out-licensing strategies by identifying prospective partners to enhance and expand business potential and scope
Identifying the upcoming leaders in the Anticoagulants market in the coming years.
Table of Contents
Classification of Anticoagulants on the basis of agents
Active Therapy Areas for Anticoagulants
Marketed Drugs for Anticoagulants
List of Marketed drugs with Indication and Approval date
List of marketed drugs along with Dosage Form and Strength
Type of Marketed Anticoagulants
Marketed Anticoagulants Patent Details
Withdrawal and Discontinued Drugs
Marketed anticoagulants for each Indication
Sales of Major players in Market
Forecasted Sales of Major players in Market
Pipeline Drugs for Anticoagulants
Clinical profile of Phase III pipeline molecules
Pipeline drugs by Phases
Pipeline drugs by Mechanism of Action
Pipeline drugs by Route of Administration
Pipeline drugs by Molecule Type
Profile of Pipeline Drugs
Phase III/ Late Stage Molecules
Phase II/ Mid Stage Molecules
Phase I/Early Stage Molecules
Pre-Clinical Stage Profiles
Antidotes for Anticoagulants
Prevalent Indications for Anticoagulants